Related Experiment Videos
Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and
1Department of Neurologic Sciences, Rush Medical College, Chicago, Ill, USA. Philip_B_Gorelick@rush.edu
Insights
Inflammation is a key factor in cardiovascular disease and stroke. New therapies like statins, ACE inhibitors, and vitamins show promise in stabilizing atherosclerotic plaques and preventing strokes.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Inflammation Research
Background:
- Atherosclerosis is an inflammatory disease, prompting research into novel risk factors beyond conventional ones.
- Vulnerable atherosclerotic plaques are a primary target for new medical strategies in stroke and cardiovascular disease prevention.
Purpose of the Study:
- To review inflammation as a potential stroke risk factor.
- To explore unifying mechanisms in ischemic stroke pathogenesis.
- To discuss emerging stroke prevention therapies.
Main Methods:
- Review of current literature on inflammation and stroke.
- Analysis of mechanisms underlying ischemic stroke.
- Evaluation of novel therapeutic agents for stroke prevention.
Main Results:
- Inflammation is identified as a significant risk factor for stroke.
- Emerging therapies including statin agents, angiotensin-converting enzyme inhibitors, and vitamins show potential.
- These agents may reduce inflammation, stabilize atherosclerotic plaques, or offer other protective effects.
Conclusions:
- Statin agents, angiotensin-converting enzyme inhibitors, and vitamins represent promising additions to stroke prevention strategies.
- These agents may complement traditional antithrombotic treatments.
- Further research is warranted to fully elucidate their role in stroke prevention.
Background:
It is estimated that about half of cardiovascular disease risk is explained by conventional risk factors. The realization that atherosclerosis is an inflammatory disease has led to a search for new stroke and cardiovascular disease risk factors and treatments. As such, the vulnerable atherosclerotic plaque has become the main focus for new medical strategies for plaque stabilization and stroke prevention.
Summary Of Review:
In this invited review, I discuss inflammation as a possible risk factor for stroke, unifying mechanisms in ischemic stroke pathogenesis, and new avenues for stroke prevention---statin agents, angiotensin-converting enzyme inhibitors, and vitamins. These new stroke prevention therapies may help to reduce inflammation, serve to stabilize the atherosclerotic plaque, or act by other protective mechanisms.
Conclusion:
Beyond the traditional antithrombotic agents, statin agents, angiotensin-converting enzyme inhibitors, and vitamins may prove to be important additions to our armamentarium for stroke prevention.